Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock. (PLAQSIS)
Pro-inflammatory Role of Blood Platelets in Critically Ill Patients With Septic Shock: an Observational Study.
Sponsor: MSD France
This observational or N/A phase trial investigates Septic Shock and is currently completed. MSD France leads this study, which shows 12 recorded versions since 2020 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
Status: Recruiting → Completed
-
Aug 2023 — May 2024 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jul 2023 — Aug 2023 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
▶ Show 7 earlier versions
-
Dec 2021 — Jul 2023 [monthly]
Recruiting
-
Sep 2021 — Dec 2021 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Jun 2020 — Nov 2020 [monthly]
Not Yet Recruiting
-
Nov 2019 — Jun 2020 [monthly]
Not Yet Recruiting
-
Oct 2019 — Nov 2019 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- MSD France
- University Hospital, Bordeaux
For direct contact, visit the study record on ClinicalTrials.gov .